Philip Kern
Clinical trials sponsored by Philip Kern, explained in plain language.
-
Bladder drug shows promise for prediabetes in new trial
Disease control Recruiting nowThis study tests whether mirabegron, a drug currently used for overactive bladder, can improve blood sugar control and activate calorie-burning brown fat in people with prediabetes. About 65 adults with prediabetes and a BMI between 27 and 45 will take the drug for several weeks.…
Phase: PHASE2 • Sponsor: Philip Kern • Aim: Disease control
Last updated May 26, 2026 02:23 UTC
-
Could a bladder drug and an ED drug together beat prediabetes?
Disease control Recruiting nowThis study tests whether two approved drugs, mirabegron and tadalafil, can improve how the body handles sugar in people with prediabetes and obesity. About 96 adults will take one or both drugs or a placebo for 14 weeks. The goal is to see if these drugs can reverse prediabetes a…
Phase: PHASE4 • Sponsor: Philip Kern • Aim: Disease control
Last updated May 14, 2026 12:06 UTC